Skip to main content
Back to News
OpenEvidence has secured 250 million dollars at a 12 billion dollar valuation, cementing its role as...
Funding
1 min read
US

OpenEvidence has secured 250 million dollars at a 12 billion dollar valuation, cementing its role as...

The AMW Read

The $12B valuation exceeds the cross.Β§D threshold and establishes OpenEvidence as a top-tier vertical leader, validating the 'Bio-platform bull' debate frame via massive scale.
NoveltySignificance
Healthcare & Bio Β· Player MapCapital Cycles

OpenEvidence has secured 250 million dollars at a 12 billion dollar valuation, cementing its role as the primary AI infrastructure for U.S. healthcare. With 40 percent of domestic physicians already using the tool to manage 100 million patient consultations, the platform effectively solves the critical medical information overload crisis. By utilizing a conductor AI to route queries to specialized sub-specialty models, it achieves clinical accuracy that general models cannot match. This milestone signals a systemic shift toward specialized medical superintelligence as an essential daily utility for global patient safety. πŸ©ΊπŸš€

#OpenEvidence #HealthTech #GenerativeAI #MedicalAI #StartupFunding

How This Connects

Based on Healthcare & Bio Β· Player Map

  1. 1w agoIsomorphic Labs raises $2.1B led by Thrive Capital in largest AI drug-discovery roundIsomorphic Labs
  2. 2w agoIsomorphic Labs nears $2 billion funding round for AI drug discoveryIsomorphic Labs
  3. 3w agoOpenAI model outperforms doctors in ER diagnoses, achieving 67% accuracy vs 55%OpenAI
  4. 1mo agoOpenAI Launches GPT-Rosalind, a Specialized Frontier Model for Life Sciences Research and Drug DiscoveryOpenAI
  5. 4mo agoOpenEvidence has secured 250 million dollars at a 12 billion dollar valuation, cementing its role as... Β· THIS ARTICLE

Related News

More news from OpenEvidence

Stay updated with the latest news and announcements from OpenEvidence.

View all OpenEvidence news

Discover AI Startups

Explore 2,000+ AI companies with VC-grade analysis, funding data, and investment insights.

Explore Dashboard